Startseite › Multiples Myelom › New York › Queens
Klinische Studien zu Multiples Myelom in Queens, NY
20 Studien zu Multiples Myelom suchen Teilnehmer an Standorten in und um Queens (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi entfernt
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Teilnehmer gesuchtPhase 3
- NYU Winthrop, Mineola · 11 mi entfernt
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Teilnehmer gesuchtPhase 3
- Northwell Health Cancer Institute, Lake Success · 9 mi entfernt
- NYU Langone Hospital Long Island, Mineola · 11 mi entfernt
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Teilnehmer gesuchtPhase 3
- MSK Nassau, Uniondale · 13 mi entfernt
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Teilnehmer gesuchtPhase 2
- Queens Cancer Center, Rego Park · 3 mi entfernt
- Cohen Children's Medical Center, New Hyde Park · 9 mi entfernt
- Northwell Health Monter Cancer Center, Lake Success · 9 mi entfernt
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi entfernt
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Teilnehmer gesuchtPhase 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mi entfernt
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi entfernt
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Teilnehmer gesuchtPhase 3
- MSK Nassau, Uniondale · 13 mi entfernt
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Teilnehmer gesuchtPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Teilnehmer gesuchtPhase 3
- Research Site, New Hyde Park · 9 mi entfernt
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Teilnehmer gesuchtBeobachtungsstudie
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi entfernt
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Teilnehmer gesuchtPhase 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Teilnehmer gesuchtPhase 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi entfernt
A Dietary Study for People With Multiple Myeloma
Teilnehmer gesucht
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Teilnehmer gesuchtPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi entfernt
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mi entfernt
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Teilnehmer gesucht
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi entfernt
Multiples Myelom-Studien in anderen Städten
- New York City, NY60 Studien
- Boston, MA42 Studien
- Atlanta, GA41 Studien
- Houston, TX38 Studien
- Durham, NC37 Studien
- Nashville, TN32 Studien
- Denver, CO27 Studien
- Rochester, MN24 Studien
- St. Louis, MO24 Studien
- Columbus, OH24 Studien
- Baldwin Park, CA23 Studien
- Chicago, IL22 Studien
Weitere Studien in Queens
- Brustkrebs63 Studien
- Nichtkleinzelliges Lungenkarzinom49 Studien
- Kolorektales Karzinom31 Studien
- Metastasierender Krebs28 Studien
- Eierstockkrebs28 Studien
- Prostatakrebs27 Studien
- Krebs (alle Arten)26 Studien
- Endometriumkarzinom25 Studien
- Lungenkrebs22 Studien
- Akute myeloische Leukämie21 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich20 Studien
- Bauchspeicheldrüsenkrebs20 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.